NCT05493761 Effect of Anti-osteoporotic Medications on Nonalcoholic Fatty Liver Disease Status ACTIVE_NOT_RECRUITING Phase PHASE4
NCT05435768 PraG With RANKL Inhibitor for the Treatment of Advanced Multiple Metastatic Solid Tumors Status UNKNOWN Phase N/A
NCT05419427 Denosumab Biosimilar Injection in Post Menopausal Women With Osteoporosis Status RECRUITING Phase PHASE3
NCT05419050 Study of Denosumab for Prevention of Skeletal Disease Progression in Children With Fibrous Dysplasia Status COMPLETED Phase PHASE2
NCT05415657 Denosumab Effect on Bone Quality and Function After Lumbar Fusion Surgery Status COMPLETED Phase NA
NCT05402865 A Real-world Study on Patients of Unresectable Giant Cell Tumor of Bone Status COMPLETED Phase N/A
NCT05395091 Multicenter Study in Postmenopausal Women With Osteoporosis, ALVOBOND Status COMPLETED Phase PHASE3
NCT05278338 Efficacy and Safety of JMT103 in the Treatment of Postmenopausal Women With Osteoporosis Status UNKNOWN Phase PHASE2
NCT05106517 Denosumab vs Zoledronic Acid and Osteoporotic Compression Fracture Status UNKNOWN Phase PHASE2/PHASE3
NCT05101018 Treatment With Romosozumab Versus Denosumab to Improve Bone Mineral Density and Architecture in Subacute SCI Status ACTIVE_NOT_RECRUITING Phase PHASE4
NCT05010590 Anabolic Therapy in Postmenopausal Osteoporosis Status ACTIVE_NOT_RECRUITING Phase PHASE4
NCT04907851 A Study to Assess RXC004 Efficacy in Advanced Solid Tumours After Progression on Standard of Care (SoC) Therapy (PORCUPINE2) Status COMPLETED Phase PHASE2
NCT04907539 A Study to Assess Efficacy of RXC004 +/- Nivolumab in Ring Finger Protein 43 (RNF43) or R-spondin (RSPO) Aberrated, Metastatic, Microsatellite Stable, Colorectal Cancer After Progression on Standard of Care (SOC) Status COMPLETED Phase PHASE2
NCT04711109 Studying the Effect of Denosumab on Preventing Breast Cancer in Women With a BRCA1 Germline Mutation Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT04621318 Pharmacokinetics, Pharmacodynamics, Safety, Tolerability, and Immunogenicity Study of SB16 in Healthy Male Subjects Status COMPLETED Phase PHASE1
NCT04232657 Romosozumab to Improve Bone Mineral Density and Architecture in Chronic SCI Status ACTIVE_NOT_RECRUITING Phase PHASE2